Cardiac Cannula Market Report and Future Trend
Introduction:
The Global Cardiac Cannula Market is witnessing significant growth, driven by the increasing prevalence of cardiovascular diseases, rising number of cardiac surgeries, and growing adoption of advanced cardiopulmonary bypass procedures. Cardiac cannulas are essential medical devices used during open-heart surgeries and extracorporeal circulation procedures to facilitate blood flow management. Technological advancements in cardiac surgical instruments, increasing healthcare expenditure, and growing investments in cardiovascular care infrastructure are expected to support the long-term expansion of the market globally.
Get Free Sample Of This Premium Report:
https://www.decisionsadvisors.com/request-sample/DAR4401
Cardiac Cannula Market Insights
Based on Deep Market Insights findings, the Global Cardiac Cannula Market was valued at USD 254.88 Million in 2024 and is expected to reach USD 517.20 Million by 2035.
From 2025 to 2035, the market is expected to grow at a CAGR of 6.64%.
Within the Product Type category, Arterial Cannulas accounted for a significant market share due to their extensive use in cardiopulmonary bypass procedures and cardiac surgeries.
Over the forecast period, Minimally Invasive Cardiac Surgery Cannulas and Advanced Perfusion Technologies are anticipated to witness strong growth owing to increasing demand for less invasive procedures, improved patient outcomes, and continuous innovations in cardiac surgical devices.
Other Key Findings
• Asia-Pacific is expected to emerge as the fastest-growing regional market during the forecast period, driven by expanding healthcare infrastructure, rising cardiovascular disease burden, and increasing surgical procedure volumes.
• North America continues to represent a major revenue-generating market due to advanced healthcare systems and high adoption of innovative cardiac surgical technologies.
• Europe remains a significant regional market supported by favorable healthcare policies and growing investments in cardiovascular treatment facilities.
• Increasing focus on improving surgical outcomes, patient safety, and procedural efficiency continues to drive market expansion globally.
Report Summary
Report Scope
Details
|
Parameter |
Information |
|
Base Year for Study |
2024 |
|
Study Period |
2021–2035 |
|
Historical Period |
2021–2024 |
|
Forecast Period |
2025–2035 |
|
Market Size In 2024 |
USD 254.88 Million |
|
Market Size In 2035 |
USD 517.20 Million |
|
Largest Region |
North America |
|
Fastest Growing Region |
Asia-Pacific |
|
3rd Largest Region |
Europe |
|
Units |
Revenue in USD Million |
|
CAGR |
6.64% (2025–2035) |
Segmentation Covered
|
Category |
Segments |
|
Product Type |
1. Arterial Cannulas 2. Venous Cannulas 3. Cardioplegia Cannulas 4. Vent Cannulas 5. Others |
|
Application |
1. Cardiopulmonary Bypass Surgery 2. Extracorporeal Membrane Oxygenation (ECMO) 3. Heart Transplantation 4. Other Cardiac Procedures |
|
Material |
1. Polyvinyl Chloride (PVC) 2. Silicone 3. Polyurethane 4. Others |
|
End User |
1. Hospitals 2. Cardiac Centers 3. Ambulatory Surgical Centers 4. Specialty Clinics |
|
Region |
1. North America 2. Europe 3. Asia-Pacific 4. Latin America 5. Middle East & Africa |
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Drivers, Industry Trends, Technology Advancements, Regulatory Landscape, Cardiovascular Procedure Analysis, Supply Chain Assessment, and Regional Analysis.
Companies
Medtronic plc, LivaNova PLC, Terumo Corporation, Edwards Lifesciences Corporation, Getinge AB, Boston Scientific Corporation, Teleflex Incorporated, Nipro Corporation, Abbott Laboratories, and Braile Biomedica.
Want detailed insights, forecasts, and competitive analysis?
Check out the full report now:
https://www.decisionsadvisors.com/reports/cardiac-cannula-market
Connect with us
- USA - +1 303 800 4326
- APAC - +1 303 800 4326
- sales@sphericalinsights.com